Skip to content

NEWS & MEDIA

Media Release

Kinoxis Therapeutics

Melbourne, Australia, 5 May 2023

Kinoxis Therapeutics partners with Boehringer Ingelheim to develop novel treatments for psychiatric patients with social dysfunction symptoms.

Follow us on social media

stay up to date with the latest in Kinoxis research & news